secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001638833-24-000110
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q1 revenue up 7.7% to $717.4M, Adjusted EBITDA $97.5M; raises FY outlook
--------------------------------------------------------------------------------

- Net loss $12.4M; Adjusted EBITDA $97.5M (+8.2% YoY); margin 13.6%.
- Same-facility revenue +10.2% YoY with 8.8% revenue per case increase and 1.3% case growth.
- FY 2024 guidance raised: revenue at least $3.05B, Adjusted EBITDA at least $505M.
- Completed refinancing of term loan and unsecured notes; no material debt maturities until 2030.
- Cash $185.2M; revolver capacity $607.3M; net debt/EBITDA ratio ~3.5x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/0001638833-24-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000110/sgry-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001638833-24-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer